Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund

Compañía Compartir, %
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. 2.15
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc. 1.9
Dianthus Therapeutics, Inc. Dianthus Therapeutics, Inc. 1.38
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. 1.14
Bicara Therapeutics Inc. Common Stock Bicara Therapeutics Inc. Common Stock 0.87
NewAmsterdam Pharma Company N.V. NewAmsterdam Pharma Company N.V. 0.48

Categoría Cantidad
Healthcare 4